The Development and Prevalidation of an in Vitro Mutagenicity Assay Based on MutaMouse Primary Hepatocytes, Part II: Assay Performance for the Identification of Mutagenic Chemicals

Overview

Journal Environ Mol Mutagen

Specialties Environmental Health
Molecular Biology

Date 2019 Feb 5

PMID 30714215

Citations 1

Authors

Julie A Cox

Edwin P Zwart

Mirjam Luijten

Paul A White

Affiliations

Soon will be listed here.

Abstract

As demonstrated in Part I, cultured MutaMouse primary hepatocytes (PHs) are suitable cells for use in an in vitro gene mutation assay due to their metabolic competence, their "normal" phenotype, and the presence of the MutaMouse transgene for reliable mutation scoring. The performance of these cells in an in vitro gene mutation assay is evaluated in this study, Part II. A panel of 13 mutagenic and nonmutagenic compounds was selected to investigate the performance of the MutaMouse PH in vitro gene mutation assay. The nine mutagens represent a range of classes of chemicals and include mutagens that are both direct-acting and requiring metabolic activation. All the mutagens tested, except for ICR 191, elicited significant, concentration-dependent increases in mutant frequency (MF) ranging from 2.6- to 14.4-fold over the control. None of the four nonmutagens, including two misleading, or "false," positives (i.e., tertiary butylhydroquinone [TBHQ] and eugenol), yielded any significant increases in MF. The benchmark dose covariate approach facilitated ranking of the positive chemicals from most (i.e., 3-nitrobenzanthrone [3-NBA], benzo[a]pyrene [BaP], and aflatoxin B [AFB1]) to least (i.e., N-ethyl-N-nitrosourea [ENU]) potent. Overall, the results of this preliminary validation study suggest that this assay may serve as a complimentary tool alongside the standard genotoxicity test battery. This study, alongside Part I, illustrates the promise of MutaMouse PHs for use in an in vitro gene mutation assay, particularly for chemicals requiring metabolic activation. Environ. Mol. Mutagen. 60:348-360, 2019. © 2019 The Authors. Environmental and Molecular Mutagenesis published by Wiley Periodicals, Inc. on behalf of Environmental Mutagen Society.

Citing Articles

In vitro mutagenicity of selected environmental carcinogens and their metabolites in MutaMouse FE1 lung epithelial cells.

Holzl-Armstrong L, Naevisdal A, Cox J, Long A, Chepelev N, Phillips D Mutagenesis. 2021; 35(6):453-463.

PMID: 33399867 PMC: 7846080. DOI: 10.1093/mutage/geaa032.

References

Zwart E, Schaap M, van den Dungen M, Braakhuis H, White P, van Steeg H . Proliferating primary hepatocytes from the pUR288 lacZ plasmid mouse are valuable tools for genotoxicity assessment in vitro. Environ Mol Mutagen. 2012; 53(5):1-8. DOI: 10.1002/em.21700. View

HAYNES R . Mutagenesis and mathematics: the allure of numbers. Environ Mol Mutagen. 1989; 14(3):200-5. DOI: 10.1002/em.2850140308. View

Kim J, Stansbury K, Walker N, Trush M, Strickland P, Sutter T . Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis. 1998; 19(10):1847-53. DOI: 10.1093/carcin/19.10.1847. View

Buick J, Moffat I, Williams A, Swartz C, Recio L, Hyduke D . Integration of metabolic activation with a predictive toxicogenomics signature to classify genotoxic versus nongenotoxic chemicals in human TK6 cells. Environ Mol Mutagen. 2015; 56(6):520-34. PMC: 4506226. DOI: 10.1002/em.21940. View

Kirkland D, Kasper P, Muller L, Corvi R, Speit G . Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop. Mutat Res. 2008; 653(1-2):99-108. DOI: 10.1016/j.mrgentox.2008.03.008. View

Nishi Y, Hasegawa M, Taketomi M, Ohkawa Y, Inui N . Comparison of 6-thioguanine-resistant mutation and sister chromatid exchanges in Chinese hamster V79 cells with forty chemical and physical agents. Cancer Res. 1984; 44(8):3270-9. View

Hoffmann D, Hecht S . Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. Cancer Res. 1985; 45(3):935-44. View

Mitchell A, Auletta A, CLIVE D, Kirby P, Moore M, Myhr B . The L5178Y/tk+/- mouse lymphoma specific gene and chromosomal mutation assay a phase III report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1998; 394(1-3):177-303. DOI: 10.1016/s1383-5718(97)00115-0. View

Jeffrey A . DNA modification by chemical carcinogens. Pharmacol Ther. 1985; 28(2):237-72. DOI: 10.1016/0163-7258(85)90013-0. View

10.

Lambert I, Singer T, Boucher S, Douglas G . Detailed review of transgenic rodent mutation assays. Mutat Res. 2005; 590(1-3):1-280. DOI: 10.1016/j.mrrev.2005.04.002. View

11.

Seglen P . Preparation of isolated rat liver cells. Methods Cell Biol. 1976; 13:29-83. DOI: 10.1016/s0091-679x(08)61797-5. View

12.

Preisler V, Caspary W, Hoppe F, Hagen R, Stopper H . Aflatoxin B1-induced mitotic recombination in L5178Y mouse lymphoma cells. Mutagenesis. 2000; 15(1):91-7. DOI: 10.1093/mutage/15.1.91. View

13.

Taft S, Liber H, Skopek T . Mutational spectrum of ICR-191 at the hprt locus in human lymphoblastoid cells. Environ Mol Mutagen. 1994; 23(2):96-100. DOI: 10.1002/em.2850230204. View

14.

Luijten M, Zwart E, Dolle M, de Pooter M, Cox J, White P . Evaluation of the LacZ reporter assay in cryopreserved primary hepatocytes for In vitro genotoxicity testing. Environ Mol Mutagen. 2016; 57(9):643-655. DOI: 10.1002/em.22063. View

15.

Storer R, Kraynak A, McKelvey T, Elia M, Goodrow T, Deluca J . The mouse lymphoma L5178Y Tk+/- cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutat Res. 1997; 373(2):157-65. DOI: 10.1016/s0027-5107(96)00227-8. View

16.

Yamazaki H, Inui Y, Yun C, Guengerich F, Shimada T . Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis. 1992; 13(10):1789-94. DOI: 10.1093/carcin/13.10.1789. View

17.

Heflich R, Neft R . Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites. Mutat Res. 1994; 318(2):73-114. DOI: 10.1016/0165-1110(94)90025-6. View

18.

Fowler P, Smith R, Smith K, Young J, Jeffrey L, Kirkland D . Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. II. Importance of accurate toxicity measurement. Mutat Res. 2012; 747(1):104-117. DOI: 10.1016/j.mrgentox.2012.04.013. View

19.

Lorge E, Moore M, Clements J, ODonovan M, Fellows M, Honma M . Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing. Mutat Res Genet Toxicol Environ Mutagen. 2016; 809:1-15. DOI: 10.1016/j.mrgentox.2016.08.001. View

20.

Arlt V, Gingerich J, Schmeiser H, Phillips D, Douglas G, White P . Genotoxicity of 3-nitrobenzanthrone and 3-aminobenzanthrone in MutaMouse and lung epithelial cells derived from MutaMouse. Mutagenesis. 2008; 23(6):483-90. DOI: 10.1093/mutage/gen037. View